Joy M Schmitz Selected Research

Cocaine (Cocaine HCl)

12/2021	Targeting white matter neuroprotection as a relapse prevention strategy for treatment of cocaine use disorder: Design of a mechanism-focused randomized clinical trial.
10/2021	Posttraumatic stress symptom clusters differentially predict late positive potential to cocaine imagery cues in trauma-exposed adults with cocaine use disorder.
1/2021	Prevalence and Correlates of Sex Selling and Sex Purchasing among Adults Seeking Treatment for Cocaine Use Disorder.
1/2021	Plasma pro- and anti-inflammatory cytokines may relate to cocaine use, cognitive functioning, and depressive symptoms in cocaine use disorder.
1/2021	The effects of combination levodopa-ropinirole on cognitive improvement and treatment outcome in individuals with cocaine use disorder: A bayesian mediation analysis.
2/2020	Elevated Neutrophil to Lymphocyte Ratio in Older Adults with Cocaine Use Disorder as a Marker of Chronic Inflammation.
1/2020	Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder.
5/2019	A Novel, Integrated Cognitive-Behavioral Therapy for Co-Occurring Posttraumatic Stress and Substance Use Disorders: A Case Study.
1/2019	Measures of possible allostatic load in comorbid cocaine and alcohol use disorder: Brain white matter integrity, telomere length, and anti-saccade performance.
1/2019	Using a data science approach to predict cocaine use frequency from depressive symptoms.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joy M Schmitz Research Topics

Disease

18	Cocaine-Related Disorders (Cocaine Addiction) 01/2016 - 07/2004
10	Substance-Related Disorders (Drug Abuse) 10/2021 - 11/2006
7	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022 - 01/2016
5	Wounds and Injuries (Trauma) 02/2022 - 01/2016
5	Alcoholism (Alcohol Abuse) 05/2019 - 07/2004
4	Anhedonia 10/2022 - 01/2017
4	Opioid-Related Disorders (Opiate Addiction) 02/2022 - 10/2008
2	Pain (Aches) 02/2022 - 01/2022
2	Cognitive Dysfunction 12/2021 - 01/2021
2	Gambling (Pathological Gambling) 01/2021 - 07/2010
2	Inflammation (Inflammations) 01/2021 - 02/2020
2	Bipolar Disorder (Manic Depressive Psychosis) 10/2015 - 11/2009
2	Antisocial Personality Disorder (Antisocial Personality) 01/2009 - 01/2002
1	Syndrome (Syndromes) 10/2021
1	Weight Gain 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Overweight 01/2021
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 03/2019
1	Bradycardia 01/2016
1	Atherosclerosis 01/2016
1	Traumatic Brain Injuries (Traumatic Brain Injury) 06/2015
1	Schizophrenia (Dementia Praecox) 01/2015
1	Neoplasms (Cancer) 01/2014
1	Weight Loss (Weight Reduction) 04/2009
1	Marijuana Use 01/2009
1	Dizziness (Lightheadedness) 05/2007
1	Nausea 05/2007
1	Alcohol-Related Disorders 02/2004

Drug/Important Bio-Agent (IBA)

27	Cocaine (Cocaine HCl)IBA 12/2021 - 07/2004
10	Pharmaceutical PreparationsIBA 10/2022 - 01/2002
5	Levodopa (L Dopa)FDA LinkGeneric 01/2017 - 05/2007
4	Biomarkers (Surrogate Marker)IBA 02/2020 - 01/2014
3	Dopamine (Intropin)FDA LinkGeneric 07/2014 - 05/2007
3	Naltrexone (ReVia)FDA LinkGeneric 11/2009 - 07/2004
2	Opioid Analgesics (Opioids)IBA 02/2022 - 01/2022
2	TESIBA 01/2017 - 06/2015
2	Carbidopa (Lodosyn)FDA LinkGeneric 07/2014 - 05/2007
2	Methamphetamine (Desoxyn)FDA LinkGeneric 04/2009 - 10/2008
2	Nicotine FDA Link 10/2008 - 02/2004
1	MMEIBA 02/2022
1	Morphine (MS Contin)FDA LinkGeneric 02/2022
1	Aldehyde DehydrogenaseIBA 01/2022
1	AldehydesIBA 01/2022
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2021
1	Exenatide (Byetta)FDA Link 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Orexin ReceptorsIBA 01/2020
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 03/2019
1	N-nitrosoiminodiacetic acidIBA 01/2018
1	A-factor (Streptomyces)IBA 01/2016
1	Cytidine Diphosphate Choline (Citicoline)IBA 10/2015
1	Mixed Function Oxygenases (Monooxygenases)IBA 07/2014
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2012
1	Modafinil (Provigil)FDA Link 01/2012
1	Amphetamine (Amfetamine)FDA LinkGeneric 04/2009
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2007
1	Serotonin (5 Hydroxytryptamine)IBA 01/2007
1	Citalopram FDA LinkGeneric 01/2007

Therapy/Procedure

11	Therapeutics 05/2019 - 07/2004
6	Drug Therapy (Chemotherapy) 01/2022 - 07/2004
2	Length of Stay 02/2022 - 01/2015
2	Transjugular Intrahepatic Portasystemic Shunt 05/2019 - 01/2018
1	Tobacco Use Cessation Devices 01/2021
1	Nicotine Replacement Therapy 01/2021
1	Ambulatory Care (Outpatient Care) 02/2007
1	Secondary Prevention 07/2004